Phase 1 study of Aricept [donepezil] plus a behavioral strategy to improve functional tasks in vascular dementia.

Next Previous
Trial Profile

Phase 1 study of Aricept [donepezil] plus a behavioral strategy to improve functional tasks in vascular dementia.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2018

At a glance

  • Drugs Donepezil (Primary)
  • Indications Vascular dementia
  • Focus Therapeutic Use

    • Most Recent Events

    • 08 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 02 May 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 22 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top